LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 92.25 | 27.76 | 1013 | 6873 | 0.1474 | 0.5720 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 92.25 | 27.76 | 12757 | 6873 | 1.8560 | 1.1618 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 93.96 | 27.76 | 456 | 6849 | 0.0666 | 0.4222 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 93.96 | 27.76 | 11141 | 6849 | 1.6266 | 1.1263 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 93.96 | 27.76 | 936 | 6849 | 0.1367 | 0.5569 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 93.96 | 27.76 | 13022 | 6849 | 1.9013 | 1.1684 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 95.66 | 27.76 | 365 | 6712 | 0.0544 | 0.3846 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 95.66 | 27.76 | 11382 | 6712 | 1.6956 | 1.1379 | MN20160318_Q01 | E21 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 95.66 | 27.76 | 1006 | 6712 | 0.1499 | 0.5737 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.0053333 | 95.66 | 27.76 | 13395 | 6712 | 1.9955 | 1.1824 | MN20160318_Q01 | G18 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 1.95 | 27.76 | 110 | 225 | 0.4886 | 0.5777 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 1.95 | 27.76 | 1 | 225 | 0.0044 | -0.6673 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 1.95 | 27.76 | 493 | 225 | 2.1897 | 1.5927 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 3.66 | 27.76 | 252 | 283 | 0.8876 | 0.9301 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 3.66 | 27.76 | 1 | 283 | 0.0035 | -0.6287 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 3.66 | 27.76 | 627 | 283 | 2.2083 | 1.5328 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 5.36 | 27.76 | 462 | 320 | 1.4421 | 1.2187 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 5.36 | 27.76 | 1 | 320 | 0.0031 | -0.6101 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 5.36 | 27.76 | 709 | 320 | 2.2132 | 1.5050 | MN20160318_Q01 | F13 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 7.06 | 27.76 | 602 | 360 | 1.6722 | 1.2984 | MN20160318_Q01 | F04 |
| MCF 10A-H2B-mCherry | Neratinib | 0.01 | 7.06 | 27.76 | 1 | 360 | 0.0028 | -0.5930 | MN20160318_Q01 | F13 |